Loading...
WuXi AppTec Co., Ltd.
2359.HK•HKSE
Healthcare
Medical - Diagnostics & Research
HK$79.40
HK$-0.30(-0.38%)
WuXi AppTec Co., Ltd. (2359.HK) Financial Performance & Statements
Review WuXi AppTec Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-2.73%
↓ 2.73%
Operating Income Growth
-2.46%
↓ 2.46%
Net Income Growth
-1.63%
↓ 1.63%
Operating Cash Flow Growth
-7.32%
↓ 7.32%
Operating Margin
33.15%
↑ 33.15%
Gross Margin
42.32%
↑ 42.32%
Net Profit Margin
27.33%
↑ 27.33%
ROE
19.37%
↑ 19.37%
ROIC
20.66%
↑ 20.66%
WuXi AppTec Co., Ltd. (2359.HK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for WuXi AppTec Co., Ltd. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.54B | $10.46B | $9.18B | $7.98B |
| Cost of Revenue | $6.52B | $5.99B | $5.59B | $4.94B |
| Gross Profit | $5.02B | $4.47B | $3.59B | $3.04B |
| Gross Profit Ratio | $0.43 | $0.43 | $0.39 | $0.38 |
| R&D Expenses | $284.48M | $317.73M | $319.44M | $306.40M |
| SG&A Expenses | -$1.45B | $2.02B | $812.06M | $754.95M |
| Operating Expenses | $1.33B | $1.66B | $1.13B | $1.05B |
| Total Costs & Expenses | $7.85B | $7.65B | $6.72B | $5.99B |
| Interest Income | $159.45M | $150.83M | $477.61M | $161.14M |
| Interest Expense | $65.81M | $43.17M | $55.97M | $51.08M |
| Depreciation & Amortization | $0.00 | $35.50M | $696.06M | $696.06M |
| EBITDA | $3.75B | $2.85B | $3.16B | $2.45B |
| EBITDA Ratio | $0.33 | $0.27 | $0.34 | $0.31 |
| Operating Income | $3.69B | $2.81B | $2.46B | $2.31B |
| Operating Income Ratio | $0.32 | $0.27 | $0.27 | $0.29 |
| Other Income/Expenses (Net) | -$3.79M | -$7.67M | $289.34M | -$12.45M |
| Income Before Tax | $3.69B | $2.80B | $2.67B | $2.30B |
| Income Before Tax Ratio | $0.32 | $0.27 | $0.29 | $0.29 |
| Income Tax Expense | $719.39M | $483.98M | $430.17M | $338.54M |
| Net Income | $2.92B | $2.29B | $2.30B | $1.94B |
| Net Income Ratio | $0.25 | $0.22 | $0.25 | $0.24 |
| EPS | $1.01 | $0.79 | $0.79 | $0.67 |
| Diluted EPS | $1.01 | $0.79 | $0.79 | $0.66 |
| Weighted Avg Shares Outstanding | $2.88B | $2.90B | $2.90B | $2.90B |
| Weighted Avg Shares Outstanding (Diluted) | $2.90B | $2.90B | $2.91B | $2.94B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan